Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elham Gholami

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Iranian Biomedical Journal|October 6, 2025
Apyrase Protein (PsSP42) Expression in DNA Construct Transfected COS-7 CellsSamira Hosseinpour Jahednia, Hossein Rezvan, Alireza Nourian, et al.
Molecular Immunology|February 28, 2015
Vaccination with recombinant L7/L12-truncated Omp31 protein induces protection against Brucella infection in BALB/c miceMaryam Golshani, Sima Rafati, Amir Dashti, et al.
Veterinary Parasitology|November 19, 2019
Antileishmanial effect of rapamycin as an alternative approach to control Leishmania tropica infectionFatemeh Khadir, Tahereh Taheri, Sima Habibzadeh, et al.
Frontiers in Immunology|June 27, 2022
<i>Leishmania tarentolae</i> as Potential Live Vaccine Co-Expressing Distinct Salivary Gland Proteins Against Experimental Cutaneous Leishmaniasis in BALB/c Mice ModelMahya Sadat Lajevardi, Elham Gholami, Tahereh Taheri, et al.
Canadian Journal of Physiology and Pharmacology|December 22, 2021
Effect of fluoxetine treatment on neurotoxicity induced by lysolecithin in male ratsElham Gholami, Mohammad Reza Gholami, Asadollah Tavakoli, et al.
Parasite Immunology|December 8, 2019
The outcome of arginase activity inhibition in BALB/c mice hosting Leishmania tropicaShima Nahidi, Elham Gholami, Yasaman Taslimi, et al.
Experimental Parasitology|February 1, 2011
Leishmania major: Protective capacity of DNA vaccine using amastin fused to HSV-1 VP22 and EGFP in BALB/c mice modelAzam Bolhassani, Elham Gholami, Farnaz Zahedifard, et al.
Plos Neglected Tropical Diseases|July 15, 2017
Arginase activity in pathogenic and non-pathogenic species of Leishmania parasitesAlireza Badirzadeh, Tahereh Taheri, Yasaman Taslimi, et al.
Parasites & Vectors|March 10, 2026
Evaluating the effect of immunization with DNA encoding Phlebotomus sergenti apyrase protein (PsSP42) against Leishmania tropica infection in BALB/c mouse modelSamira Hosseinpour Jahednia, Hossein Rezvan, Hamzeh Sarvnaz, et al.
Plos Neglected Tropical Diseases|October 23, 2013
Human neutrophil peptide-1 (HNP-1): a new anti-leishmanial drug candidateSara Dabirian, Yasaman Taslimi, Farnaz Zahedifard, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Iranian Biomedical Journal|October 6, 2025
Apyrase Protein (PsSP42) Expression in DNA Construct Transfected COS-7 CellsSamira Hosseinpour Jahednia, Hossein Rezvan, Alireza Nourian, et al.
Molecular Immunology|February 28, 2015
Vaccination with recombinant L7/L12-truncated Omp31 protein induces protection against Brucella infection in BALB/c miceMaryam Golshani, Sima Rafati, Amir Dashti, et al.
Veterinary Parasitology|November 19, 2019
Antileishmanial effect of rapamycin as an alternative approach to control Leishmania tropica infectionFatemeh Khadir, Tahereh Taheri, Sima Habibzadeh, et al.
Frontiers in Immunology|June 27, 2022
<i>Leishmania tarentolae</i> as Potential Live Vaccine Co-Expressing Distinct Salivary Gland Proteins Against Experimental Cutaneous Leishmaniasis in BALB/c Mice ModelMahya Sadat Lajevardi, Elham Gholami, Tahereh Taheri, et al.
Canadian Journal of Physiology and Pharmacology|December 22, 2021
Effect of fluoxetine treatment on neurotoxicity induced by lysolecithin in male ratsElham Gholami, Mohammad Reza Gholami, Asadollah Tavakoli, et al.
Parasite Immunology|December 8, 2019
The outcome of arginase activity inhibition in BALB/c mice hosting Leishmania tropicaShima Nahidi, Elham Gholami, Yasaman Taslimi, et al.
Experimental Parasitology|February 1, 2011
Leishmania major: Protective capacity of DNA vaccine using amastin fused to HSV-1 VP22 and EGFP in BALB/c mice modelAzam Bolhassani, Elham Gholami, Farnaz Zahedifard, et al.
Plos Neglected Tropical Diseases|July 15, 2017
Arginase activity in pathogenic and non-pathogenic species of Leishmania parasitesAlireza Badirzadeh, Tahereh Taheri, Yasaman Taslimi, et al.
Parasites & Vectors|March 10, 2026
Evaluating the effect of immunization with DNA encoding Phlebotomus sergenti apyrase protein (PsSP42) against Leishmania tropica infection in BALB/c mouse modelSamira Hosseinpour Jahednia, Hossein Rezvan, Hamzeh Sarvnaz, et al.
Plos Neglected Tropical Diseases|October 23, 2013
Human neutrophil peptide-1 (HNP-1): a new anti-leishmanial drug candidateSara Dabirian, Yasaman Taslimi, Farnaz Zahedifard, et al.
Pageof 3